Back
Ovid Therapeutics, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
40
OVID
Ovid Therapeutics, Inc.
Last Price:
$1.79
Seasonality Move:
-12.18%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and OVID is experiencing selling pressure, which indicates risk of future bearish movement.
Ovid Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.6 | Buy |
| 20-day SMA: | 1.62 | Buy |
| 50-day SMA: | 1.51 | Buy |
| 200-day SMA: | 0.86 | Buy |
| 8-day EMA: | 1.66 | Buy |
| 20-day EMA: | 1.59 | Buy |
| 50-day EMA: | 1.41 | Buy |
| 200-day EMA: | 0.69 | Buy |
Ovid Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.07 | Buy |
| Relative Strength Index (14 RSI): | 60.19 | Buy |
| Chaikin Money Flow: | -901730 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.42 - 1.72) | Buy |
| Bollinger Bands (100): | (1.05 - 1.67) | Buy |
Ovid Therapeutics, Inc. Technical Analysis
| Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Ovid Therapeutics, Inc. Stock
Is Ovid Therapeutics, Inc. Stock a Buy?
-
Ovid Therapeutics, Inc. share price is 1.78 while OVID 8-day simple moving average is 1.60, which is a Buy signal.
-
The stock price of OVID is 1.78 while Ovid Therapeutics, Inc. 20-day SMA is 1.62, which makes it a Buy.
-
Ovid Therapeutics, Inc. 50-day simple moving average is 1.51 while OVID share price is 1.78, making it a Buy technically.
-
OVID stock price is 1.78 and Ovid Therapeutics, Inc. 200-day simple moving average is 0.86, creating a Buy signal.
OVID Technical Analysis vs Fundamental Analysis
Sell
40
Ovid Therapeutics, Inc. (OVID)
is a Sell
Is Ovid Therapeutics, Inc. a Buy or a Sell?
-
Ovid Therapeutics, Inc. stock is rated a SellThe current Ovid Therapeutics, Inc. [OVID] share price is $1.78. The Score for OVID is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
Ovid Therapeutics, Inc. Stock Info
Market Cap:
126.8M
Price in USD:
1.78
Share Volume:
1.1M
Ovid Therapeutics, Inc. 52-Week Range
52-Week High:
2.01
52-Week Low:
0.24
Sell
40
Ovid Therapeutics, Inc. (OVID)
is a Sell
Ovid Therapeutics, Inc. Share Price Forecast
-
What is the Ovid Therapeutics, Inc. stock price today?The Ovid Therapeutics, Inc. stock price is 1.78 USD today.
-
Will OVID stock go up or go down?Ovid Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Ovid Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Ovid Therapeutics, Inc. is overvalued.
Is Ovid Therapeutics, Inc. Stock a Buy?
-
Ovid Therapeutics, Inc. share price is 1.78 while OVID 8-day exponential moving average is 1.66, which is a Buy signal.
-
The stock price of OVID is 1.78 while Ovid Therapeutics, Inc. 20-day EMA is 1.59, which makes it a Buy.
-
Ovid Therapeutics, Inc. 50-day exponential moving average is 1.41 while OVID share price is 1.78, making it a Buy technically.
-
OVID stock price is 1.78 and Ovid Therapeutics, Inc. 200-day simple moving average is 0.69, creating a Buy signal.
Fundamental Analysis of Ovid Therapeutics, Inc.
Is Ovid Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.04 per share, and an increase next year of $0.08 per share.
Technical Analysis of Ovid Therapeutics, Inc.
Should I short Ovid Therapeutics, Inc. stock?
-
OVID Moving Average Covergence Divergence (MACD) indicator is 0.07, suggesting Ovid Therapeutics, Inc. is a Buy
-
Ovid Therapeutics, Inc. Relative Strength Index (RSI) is 60.19, which suggest Ovid Therapeutics, Inc. is overbought
-
The Bollinger Bands (25) for Ovid Therapeutics, Inc. is (1.42 - 1.72), which suggest Ovid Therapeutics, Inc. is a Buy
-
The Bollinger Bands (100) for Ovid Therapeutics, Inc. is (1.05 - 1.67), which suggest Ovid Therapeutics, Inc. is a Buy
* Ovid Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.